Insights For Helping Get First Medication Prescriptions Filled

Published Jul 17, 2013
Temple, TX, USA – There are many reasons why patients frequently do not take their medications, but we know relatively little about what affects starting treatment and getting first prescriptions filled. Since this crucial beginning period affects long-term adherence and outcomes, efforts to recognize early problems are important in helping providers quickly address potential barriers. An international team specializing in medication adherence conducted a comprehensive review of the research on initial medication over the past 45 years. Eligible articles were identified from key words, abstracts, and group discussions, and then evaluated for overall quality and carefully examined to discover how initial adherence was defined and analyzed. The study team also summarized the psychosocial and behavioral factors associated with initial adherence problems. Out of almost 900 articles reviewed, only 24 met final inclusion criteria. Factors associated with initial adherence included medication type, patient demographics, illness severity, health beliefs and their provider relationships.  Medication cost or copayments, however, had the greatest impact on initial adherence. Few articles reported health system factors, such as pharmacy information or hospital processes. Lead author, John Zeber, PhD, an investigator from Scott & White Healthcare and the Central Texas VA, summarized the team’s work, stating “Defining initial adherence is complex, but further efforts are essential for recognizing what influences patients at they start treatment. Since interventions have been developed for many adherence barriers, it is crucial that researchers and providers work together to improve adherence and subsequent outcomes.”  The full study, “Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence: A Report of the ISPOR Medication Adherence & Persistence Special Interest Group,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.

ISPOR Champions Research Transparency With Launch of Open Science Badges

Aug 4, 2025

ISPOR introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×